Skip to main content

Want a detailed portfolio tracker?

Immuron (IMRN) P/E (2017 - 2026)

Immuron (IMRN) P/E from Jun 9, 2017 to Jul 21, 2026. The TTM Immuron (IMRN) P/E is -1.34. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immuron (IMRN)

YearP/EChange
2026-1.34+60.00%
2025-0.84-37.57%
2024-1.34-68.07%
2023-4.21+206.55%
2022-1.37-11.67%
2021-1.56-60.83%
2020-3.97+25.10%
2019-3.17-19.16%
2018-3.93+150.42%
2017-1.57N/A

Comparison Immuron (IMRN) P/E with competitors

Immuron (IMRN) P/E is -1.34.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.13%
NBYStablecoin Development Corp0.00-100.32%
ENLVEnlivex Ltd0.07-105.57%
FGENFibroGen Inc0.24-117.87%
CHRSCoherus Biosciences Inc0.85-163.18%
FBIOFortress Biotech Inc0.95-170.66%
ORMPOramed Pharmaceuticals Inc1.50-211.91%
AGENAgenus Inc3.01-324.07%
INVAInnoviva Inc3.15-334.82%
VXRTVaxart Inc3.55-364.29%
CRMDCorMedix Inc3.63-370.15%
CVACCureVac N.V.4.45-430.99%
GLPGGalapagos NV4.86-461.76%
SRPTSarepta Therapeutics Inc4.88-463.48%
ABEOAbeona Therapeutics Inc5.39-501.11%
ABUSArbutus Biopharma Corp5.60-516.61%
ZVRAZevra Therapeutics Inc5.89-538.32%
SPROSpero Therapeutics Inc6.23-563.72%
CGENCompugen Ltd6.31-570.09%
RIGLRigel Pharmaceuticals6.87-611.64%
SLXNSilexion Therapeutics Corp7.30-643.21%
OMEROmeros Corporation9.26-789.34%
AUPHAurinia Pharmaceuticals Inc9.58-813.63%
PLXProtalix BioTherapeutics Inc10.89-910.86%
ACADAcadia Pharmaceuticals Inc11.73-973.22%
TBPHTheravance Biopharma Inc12.26-1012.95%
ADMAAdma Biologics Inc12.42-1024.57%
HRMYHarmony Biosciences Holdings Inc13.82-1128.95%
SABSSAB Biotherapeutics Inc14.14-1152.48%
NAGENiagen Bioscience Inc14.82-1203.25%
INCYIncyte Corp15.82-1278.03%
REGNRegeneron Pharmaceuticals Inc15.86-1280.57%
PBYIPuma Biotechnology Inc17.32-1389.20%
CPRXCatalyst Pharmaceuticals Inc17.44-1398.41%
EXELExelixis Inc17.54-1405.75%
TGTXTG Therapeutics Inc18.97-1512.08%
MDXGMimedx Group Inc20.55-1630.19%
XOMAXOMA Royalty Corp22.87-1803.13%
ARGXArgen X SE24.30-1909.10%
CTMXCytomX Therapeutics Inc24.82-1948.05%
XOMAOXOMA Royalty Corp25.34-1987.04%
HALOHalozyme Therapeutics Inc25.62-2007.81%
XOMAPXOMA Royalty Corp25.67-2011.26%
VRTXVertex Pharmaceuticals Inc27.99-2184.34%
RPRXRoyalty Pharma plc - Class A28.69-2235.93%
SLNOSoleno Therapeutics Inc29.02-2260.33%
ASNDAscendis Pharma A/S30.09-2340.01%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2922.73%
APLSApellis Pharmaceuticals Inc39.02-3005.32%
BMRNBiomarin Pharmaceutical Inc42.21-3242.88%
KRYSKrystal Biotech Inc45.34-3476.04%
ONCBeiGene Ltd69.54-5277.62%
PHARPharming Group N.V.75.03-5686.02%
TECHBio-Techne Corp101.96-7691.30%
VCELVericel Corp109.92-8284.18%
ALNYAlnylam Pharmaceuticals Inc117.96-8883.07%
GMABGenmab140.29-10545.33%
TLXTelix Pharmaceuticals Ltd162.15-12173.07%
CORTCorcept Therapeutics Inc212.86-15948.28%